引用本文: | 蒋苏静, 谢聪颖, 卢红莲. Durvalumab治疗放化疗后Ⅲ期非小细胞肺癌患者的总生存期获益[J]. 循证医学, 2020, 20(1): 49-52. DOI: 10.12019/j.issn.1671-5144.2020.01.011 |
Citation: | JIANG Su-jing, XIE Cong-ying, LU Hong-lian. Overall Survival with Durvalumab after Chemoradio-therapy in Stage Ⅲ NSCLC[J]. Journal of Evidence-Based Medicine, 2020, 20(1): 49-52. DOI: 10.12019/j.issn.1671-5144.2020.01.011 |